Does PANTOPRAZOLE Cause Malignant neoplasm progression? 95 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Malignant neoplasm progression have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.1% of all adverse event reports for PANTOPRAZOLE.
95
Reports of Malignant neoplasm progression with PANTOPRAZOLE
0.1%
of all PANTOPRAZOLE reports
15
Deaths
49
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PANTOPRAZOLE?
Of the 95 reports, 15 (15.8%) resulted in death, 49 (51.6%) required hospitalization, and 5 (5.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 95 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE Cause?
Chronic kidney disease (28,127)
Acute kidney injury (15,961)
Renal failure (11,543)
End stage renal disease (8,523)
Renal injury (7,070)
Drug ineffective (5,487)
Off label use (4,279)
Pain (4,057)
Dyspnoea (4,052)
Fatigue (3,797)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PANTOPRAZOLE Alternatives Have Lower Malignant neoplasm progression Risk?
PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS
PANTOPRAZOLE vs PANTOTHENIC ACID
PANTOPRAZOLE vs PAPAVERINE
PANTOPRAZOLE vs PARACETAMOL
PANTOPRAZOLE vs PARATHYROID HORMONE